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Cronobacter Sakazakii Bacteremia in a 76-year-old Woman: A Case
Report
Amy Kang,1 Nancy Garcia,2 Bhanu Sud2 & Lee Nguyen3
Abstract
Cronobacter sakazakii, commonly found in contaminated infant formula and thereby
causes infantile bacteremia, is rarely associated with adult bacteremia. We present the
tenth case of C. sakazakii bacteremia in adults. The patient is a 76-year-old woman
who resides in a skilled nursing facility and presents with risk factors including
bullous pemphigoid, Type II diabetes mellitus, hypertension, hyperlipidemia, chronic
kidney disease, and anemia. The therapy was started with intravenous ciprofloxacin
and vancomycinempirically. After consultation with an Infectious Diseases specialist,
ciprofloxacin and vancomycin was replaced with meropenem based on the patient’s
extensive bullous lesions, history of ESBL infections, and possible pneumonia.
Later, the therapy was de-escalated to intravenous ceftriaxone and vancomycin after
culture and sensitivity testing were available and clinical signs of improvements were
evident. She was sent back to her skilled nursing but was re-admitted 10-days later.
She was placed on dialysis for altered mental status secondary to acute renal failure.
Blood and urine cultures were repeated and had no evidence of bacterial growth.
Keywords: Cronobacter sakazakii; Bacteremia; antibiotics; empiric therapy

1. Introduction
Cronobacter (Enterobacter) sakazakii related infections are infrequently seen
in adults, but can be serious among people with immunocompromising conditions
and the elderly. Only nine cases of bacteremia have been previously published in the
medical literature (Emery & Weymouth, 1997; Hawkins, Lissner, & Sanford, 1991;
Jimenez & Gimenez, 1982; Lai 2001; Pribyl et al., 1985; See, Than, & Tang, 2007).
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We present a case of C. sakazakii bacteremia in a 76-year-old female who was
brought to the emergency department in December 2013 from a skilled nursing
facility (SNF) with increased confusion, left abdominal pain, and reports of fever per
family member. This patient had various co-morbid conditions including bullous
pemphigoid, Type II diabetes mellitus, hypertension, hyperlipidemia, chronic kidney
disease, anemia, and a history of Clostridium difficile and extended-spectrum betalactamase (ESBL) Enterobacteriaceae urinary tract infections, and uterine cancer with
a vague history of penicillin and sulfa allergies. Of note, she has been receiving
chronic steroid therapy for bullous pemphigoid and finishing a tapering dose of oral
vancomycin. At presentation, she had confusion, left upper quadrant abdominal
tenderness and guarding, right-sided rhonchi, and 2+ edema with notable oozing
from her lower extremities without other significant findings. Laboratory results
revealed normal leukocyte (10.3/mm3) and lowered platelet counts (82,000/mm3), but
had elevated band neutrophils (36%), elevated potassium (5.2-mEq/L), blood urine
nitrogen (105-mg/dL), creatinine (2-mg/dL), and procalcitonin (0.16-ng/mL).
Urinalysis was positive for nitrites, leukocyte esterase (3+), protein (1+), and white
blood cells (18/mm3). The chest radiograph showed a new infiltrate on the right
middle lung field. On admission, intravenous ciprofloxacin and vancomycin was
started empirically considering the patient’s allergy profile. The following morning,
the patient was seen by an Infectious Diseases specialist. The extensive bullous
lesions, history of ESBL infections, and possible pneumonia prompted the
replacement of ciprofloxacin with meropenem.
Urine, nares, and two sets of blood cultures were obtained on admission. The
urine culture had >105 colony-forming units of Proteus mirabilis, and the nares culture
identified methicillin-resistant Staphylococcus aureuspresence. After one day of
incubation, two of four blood culture bottles were positive for bacterial growth, C.
sakazakii and diphtheroid group bacteria. The Cronobacter was susceptible to the
following antibiotics: amikacin, cefepime, ceftazidime, ceftriaxone, ciprofloxacin,
ertapenem, gentamicin, meropenem, piperacillin-tazobactam, tobramycin, and
trimethoprim/sulfamethoxazole. The Cronobacter was resistant to cefazolin and
cefoxitin. The open leg wounds and probable pneumoniawere the most probable
sources of the bacteremia. The remaining chief complaint for left upper quadrant pain
was evaluated for a gastric ulcer perforation and the computerized tomography (CT)
scan of the abdomen and pelvis did not find evidence of an acute abnormalities.
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After microbiology susceptibilities were available and a clinical response to
antimicrobial therapy was evident, the patient was de-escalated to intravenous
ceftriaxone and vancomycin. Therapy was changed to account for the
fluoroquinolone-resistant, cephalosporin-sensitive Proteus mirabilis in the urine, and
possible pneumonia. Repeat blood cultures were negative for any bacterial growth.
After aggressive hydration, antibiotics, and intravenous steroids, the patient stabilized
and improved. She was sent back to her SNF to complete her antimicrobial therapy.
The patient was re-admitted 10-days later for altered mental status secondary to acute
renal failure and placed on dialysis. Blood and urine cultures were repeated and had
no evidence of bacterial growth.
2. Discussion
Previous reports of Cronobacter bacteremia resulted in mixed success. Five
of the nine previous cases resulted in patient mortality (Table 1). It has been suggested
that empiric treatment of Cronobacter infections should be include either a
carbapenem or a later generation cephalosporin (Dennison & Morris, 2002).
Effective empiric therapy is important as well as de-escalation to appropriate directed
therapy based on susceptibilities. This current case demonstrates the potential for
clinical cure with a third generation cephalosporin, and reinforces common
characteristics seen in Cronobacter bacteremia.
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Table 1: Cronobacter (Enterobacter) Sakazakii Bacteremias in Adults
Age/Gender

Treatment

Outcome

Reference

76/ male

Co-morbid
Condition(s)
Rectal adenocarcinoma

Ampicillin + gentamicin

Successful

55/ male

Diabetes

Aztreonam

Successful

75/ female

Cefuroxime; ceftriaxone;
ciprofloxacin

Successful

68/ male

Chronic atrial
fibrillation, CVA,
hypertension
CLL, alcohol abuse

Jimenez,
1982
Pribyl,
1985
Hawkins,
1991

Ceftriaxone + gentamicin

Died

39/ male

Tonsillar carcinoma

Successful

73/ female

Klatskin tumor

Died

Lai, 2001

82/ female

Abdominal aortic
aneurysm
Fungemia, cecal
volvulus
Schizophrenia, splenic
abscess

Ceftazidime + clindamycin;
cefuroxime axetil + clindamycin
Piperacillin-tazobactam+
gentamicin; imipenem
Piperacillin-tazobactam +
ofloxacin
Ceftazidime + tobramycin;
ofloxacin + tobramycin
Ceftriaxone +metronidazole;
imipenem; ciprofloxacin

Emery,
1997
Lai, 2001

Died

Lai, 2001

Died

Lai, 2001

Successful

See, 2007

76/ female
75/ female

Semicolons denotes division of initial and subsequent therapies
CVA: Cerebrovascular Accident, CLL: Chronic Lymphocytic Leukemia
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